Neuropsychiatric side effects due to a transdermal fentanyl patch: hallucinations

Basit Öğe Kaydı
dc.authorid0000-0001-7325-6646
dc.authorid0000-0001-9151-6050
dc.authorid0000-0002-4852-7915
dc.authorid0000-0003-1045-0681
dc.authorscopusid55624520600
dc.authorscopusid36460818000
dc.authorscopusid55938435500
dc.authorscopusid36461258800
dc.authorscopusid56526492500
dc.authorscopusid55856723500
dc.authorscopusid8587924200
dc.authorwosidTAYFUR, İsmail/S-2208-2017
dc.authorwosidErdogan, Mehmet Özgür/N-5852-2017
dc.contributor.authorÇolak, Sahin
dc.contributor.authorErdoğan, Mehmet Ozgur
dc.contributor.authorAfacan, Mustafa Ahmet
dc.contributor.authorKosargelir, Mehmet
dc.contributor.authorAktaş, Sezin
dc.contributor.authorTayfur, İsmail
dc.date.accessioned2022-05-11T14:37:01Z
dc.date.available2022-05-11T14:37:01Z
dc.date.issued2015
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Acil Tıp Ana Bilim Dalı
dc.description.abstractOpioid analgesics are used commonly in end-stage cancer patients for pain treatment. Central nervous system adverse effects are rare. A 73-year-old female patient was admitted to the emergency department for auditory and visual hallucinations. The patient had been receiving palliative treatment for liver, cervical, and lumbar bone metastases from an unknown origin. The patient used a transdermal fentanyl patch for palliative pain management and metoclopramide hydrochloride for nausea and vomiting. The patient had suffered weight loss of 10 kg within 5 months, and laboratory findings revealed hypoalbuminemia. The patient was considered to have experienced a fentanyl overdose, and the transdermal fentanyl patch treatment was stopped. The hallucinations improved during follow-up, and the patient was discharged with a dose adjustment. End-stage cancer patients with weight loss and hypoalbuminemia may be more prone to opioid adverse effects, such as hallucinations. The dose of fentanyl must be adjusted for weight loss, and correction of hypoalbuminemia may also lower the incidence of such adverse effects.
dc.identifier.doi10.1016/j.ajem.2014.08.051
dc.identifier.issn0735-6757
dc.identifier.issn1532-8171
dc.identifier.issue3en_US
dc.identifier.pmid25227974
dc.identifier.scopus2-s2.0-84930348304
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.ajem.2014.08.051
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8532
dc.identifier.volume33
dc.identifier.wosWOS:000351935100055
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorTayfur, İsmail
dc.language.isoen
dc.publisherW B Saunders Co-Elsevier Inc
dc.relation.ispartofAmerican Journal of Emergency Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCancer Pain
dc.titleNeuropsychiatric side effects due to a transdermal fentanyl patch: hallucinations
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
8532.pdf
Boyut:
170.81 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu